GNI Group (TSE:2160) Scaled Net Operating Assets : 0.33 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is GNI Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GNI Group's operating assets for the quarter that ended in Mar. 2024 was 円42,077 Mil. GNI Group's operating liabilities for the quarter that ended in Mar. 2024 was 円21,612 Mil. GNI Group's Total Assets for the quarter that ended in Dec. 2023 was 円62,394 Mil. Therefore, GNI Group's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.33.

GNI Group Scaled Net Operating Assets Historical Data

The historical data trend for GNI Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Scaled Net Operating Assets Chart

GNI Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.41

0.20

0.26

0.30

0.49

GNI Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.28	0.35	0.22	0.34	0.33

Competitive Comparison of GNI Group's Scaled Net Operating Assets

For the Biotechnology subindustry, GNI Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GNI Group's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where GNI Group's Scaled Net Operating Assets falls into.

GNI Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GNI Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(39184.068	-	22642.158)	/	33906.981
=	0.49

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	62394.37	-	23210.302
=	39184.068

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	26341.592	-	1750.276	-	1949.158
=	22642.158

GNI Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(42077.306	-	21612.091)	/	62394.37
=	0.33

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	65600.114	-	23522.808
=	42077.306

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	27845.914	-	1606.923	-	4626.9
=	21612.091

GNI Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of GNI Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

GNI Group (TSE:2160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (TSE:2160) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

3G6:Germany

Address

Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030

Website

http://www.gnipharma.com

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (TSE:2160) Headlines

No Headlines